MDS Virtual Congress 2021 Archives - Page 75 of 132

Markers of Parkinson-related impulsive-compulsive behaviors in the activity of single units in the subthalamic nucleus

M. Vissani, F. Micheli, G. Pecchioli, S. Ramat, A. Mazzoni (Pontedera, Italy)
Maximising UPDRS information while minimising assessment time

G. Morinan, J. Tang, J. O'Keeffe (London, United Kingdom)
MDS Basic Scientists Survey demonstrates Potential for Crosspollination between Basic Scientists and MDS

B. Bergmans, H. Tibar, M. Carecchio, S. Ibrahim El-Jafaary, M. Matarazzo, S. Perez-Lloret, R. Rajan, T. Cardoso Vale, N. Vijaratnam, T. Riestra, M. Fabbri, B. Bloem (Bruges & Ghent, Belgium)
MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS

S. Luo, N. Lapelle, P. Martin, S. Ali, C. Goetz, G. Stebbins (Durham, USA)
MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR

A. Weissbach, R. Herzog, M. Pauly, L. Hahn, I. König, S. Camargos, B. Jeon, M. Kurian, T. Opladen, N. Brüggemann, C. Klein, K. Lohmann (Lübeck, Germany)
Measures of Physical Activity in Parkinson’s Disease (MAPD)

J. Gilby, C. Carroll, J. Marsden (Plymouth, United Kingdom)
Measuring progression of Parkinson’s disease cardinal signs in the Phase 2 SPARK study

KP. Kilambi, T. Dam, J. Edgerton, T. Fox, S. Khan, J. Xiao, M. Yang, P. Bergethon (Cambridge, USA)
Medically refractory Graves’ disease presenting as chorea and carbohydrate hyperphagia in a Kenyan adolescent

N. Mongare, E. Njenga, D. Sokhi (Nairobi, Kenya)
Medication effects and validity of home-based freezing tests in Parkinson’s disease

D. Zoetewei, P. Ginis, T. Herman, D. Denk, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)
Metabolic activity and perfusion of basal ganglia in patients with hemichorea and carotid stenosis

Z. Drakulić, P. Tomše, E. Rebec, J. Jamšek, J. Pretnar Oblak, P. Miklavčič, M. Trošt, M. Kojović (Ljubljana, Slovenia)